SnoN functions as a tumour suppressor by inducing premature senescence

EMBO Journal

Volumn 28, Issue 22, 2009, Pages 3500-3513

  Pan, Deng ^a   Zhu, Qingwei ^b   Luo, Kunxin ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

P53; PML (promyelocytic leukaemia); Senescence; SnoN; Tumour suppressor

Indexed keywords

MYC PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN P53; RAS PROTEIN; SKI RELATED NOVEL PROTEIN N; SMAD PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER MODEL; CANCER REGRESSION; CELL AGING; CELL NUCLEUS INCLUSION BODY; CONTROLLED STUDY; EMBRYO; GENE FUNCTION; GENE INTERACTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL; MOUSE; NONHUMAN; ONCOGENE MYC; ONCOGENE RAS; PAPILLOMA; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SENESCENCE; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANIMALS; CARCINOGENS; CELL AGING; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; GENE KNOCK-IN TECHNIQUES; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, BIOLOGICAL; MUTANT PROTEINS; PAPILLOMA; PROTO-ONCOGENE PROTEINS; SKIN NEOPLASMS; TIME FACTORS;

EID: 70450100802     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/emboj.2009.250     Document Type: Article

References (70)

1. Balmain A, Brown K, Akhurst RJ, Fee FM (1988) Molecular analysis of chemical carcinogenesis in the skin. Br J Cancer Suppl 9: 72-75
2. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou LV, Kolettas E, Niforou K, Zoumpourlis VC, Takaoka M, Nakagawa H, Tort F, Fugger K, Johansson F, Sehested M, Andersen CL, Dyrskjot L, Orntoft T, Lukas J et al (2006) Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444: 633-637
3. Bernardi R, Pandolfi PP (2007) Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol 8: 1006-1016
4. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW (1997) Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91: 25-34
5. Bode AM, Dong Z (2004) Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 4: 793-805
6. Bonni S, Wang HR, Causing CG, Kavsak P, Stroschein SL, Luo K, Wrana JL (2001) TGF-beta induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation. Nat Cell Biol 3: 587-595
7. Boyer PL, Colmenares C, Stavnezer E, Hughes SH (1993) Sequence and biological activity of chicken snoN cDNA clones. Oncogene 8: 457-466
8. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B, Stein H, Dorken B, Jenuwein T, Schmitt CA (2005) Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436: 660-665
9. Bravou V, Antonacopoulou A, Papadaki H, Floratou K, Stavropoulos M, Episkopou V, Petropoulou C, Kalofonos H (2009) TGF-beta repressors SnoN and Ski are implicated in human colorectal carcinogenesis. Cell Oncol 31: 41-51
10. Buess M, Terracciano L, Reuter J, Ballabeni P, Boulay JL, Laffer U, Metzger U, Herrmann R, Rochlitz C (2004) Amplification of SKI is a prognostic marker in early colorectal cancer. Neoplasia 6: 207-212
11. Campisi J (2001) Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol 11: S27-S31
12. Campisi J (2005) Senescent cells, tumor suppression, and organis-mal aging: good citizens, bad neighbors. Cell 120: 513-522
13. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W, Cordon-Cardo C, Pandolfi PP (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436: 725-730
14. Chia JA, Simms LA, Cozzi SJ, Young J, Jass JR, Walsh MD, Spring KJ, Leggett BA, Whitehall VL (2006) SnoN expression is differently regulated in microsatellite unstable compared with microsatellite stable colorectal cancers. BMC Cancer 6: 252
15. Collado M, Blasco MA, Serrano M (2007) Cellular senescence in cancer and aging. Cell 130: 223-233
16. Courtois-Cox S, Jones SL, Cichowski K (2008) Many roads lead to oncogene-induced senescence. Oncogene 27: 2801-2809
17. de Stanchina E, Querido E, Narita M, Davuluri RV, Pandolfi PP, Ferbeyre G, Lowe SW (2004) PML is a direct p53 target that modulates p53 effector functions. Mol Cell 13: 523-535
18. Dellaire G, Ching RW, Ahmed K, Jalali F, Tse KC, Bristow RG, Bazett-Jones DP (2006) Promyelocytic leukemia nuclear bodies behave as DNA damage sensors whose response to DNA double-strand breaks is regulated by NBS1 and the kinases ATM, Chk2, and ATR. J Cell Biol 175: 55-66
19. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, Schurra C, Garre M, Nuciforo PG, Bensimon A, Maestro R, Pelicci PG, d'Adda di Fagagna F (2006) Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444: 638-642
20. Di Micco R, Fumagalli M, di Fagagna F (2007) Breaking news: highspeed race ends in arrest-how oncogenes induce senescence. Trends Cell Biol 17: 529-536
21. Edmiston JS, Yeudall WA, Chung TD, Lebman DA (2005) Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells. Cancer Res 65: 4782-4788
22. Efeyan A, Serrano M (2007) p53: guardian of the genome and policeman of the oncogenes. Cell Cycle 6: 1006-1010
23. Feng XH, Derynck R (2005) Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol 21: 659-693
24. Ferbeyre G, de Stanchina E, Querido E, Baptiste N, Prives C, Lowe SW (2000) PML is induced by oncogenic ras and promotes premature senescence. Genes Dev 14: 2015-2027
25. Frescas D, Guardavaccaro D, Bassermann F, Koyama-Nasu R, Pagano M (2007) JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes. Nature 450: 309-313
26. Goddard AD, Yuan JQ, Fairbairn L, Dexter M, Borrow J, Kozak C, Solomon E (1995) Cloning of the murine homolog of the leukemia-associated PML gene. Mamm Genome 6: 732-737
27. Guzman-Ayala M, Lee KL, Mavrakis KJ, Goggolidou P, Norris DP, Episkopou V (2009) Graded Smad2/3 activation is converted directly into levels of target gene expression in embryonic stem cells. PLoS ONE 4: e4268
28. Hayflick L (1965) The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 37: 614-636
29. He J, Tegen SB, Krawitz AR, Martin GS, Luo K (2003) The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins. J Biol Chem 278: 30540-30547
30. Imoto I, Pimkhaokham A, Fukuda Y, Yang ZQ, Shimada Y, Nomura N, Hirai H, Imamura M, Inazawa J (2001) SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus. Biochem Biophys Res Commun 286: 559-565
31. Levy L, Howell M, Das D, Harkin S, Episkopou V, Hill CS (2007) Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation. Mol Cell Biol 27: 6068-6083
32. Mallette FA, Ferbeyre G (2007) The DNA damage signaling pathway connects oncogenic stress to cellular senescence. Cell Cycle 6: 1831-1836 (Pubitemid 47327900)
33. Marcotte R, Wang E (2002) Replicative senescence revisited. J Gerontol A Biol Sci Med Sci 57: B257-B269
34. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM, Majoor DM, Shay JW, Mooi WJ, Peeper DS (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436: 720-724
35. Moustakas A, Souchelnytskyi S, Heldin CH (2001) Smad regulation in TGF-beta signal transduction. J Cell Sci 114: 4359-4369
36. Nagano Y, Mavrakis KJ, Lee KL, Fujii T, Koinuma D, Sase H, Yuki K, Isogaya K, Saitoh M, Imamura T, Episkopou V, Miyazono K, Miyazawa K (2007) Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-beta signaling. J Biol Chem 282: 20492-20501
37. Nomura N, Sasamoto S, Ishii S, Date T, Matsui M, Ishizaki R (1989) Isolation of human cDNA clones of ski and the ski-related gene, sno. Nucleic Acids Res 17: 5489-5500
38. Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S, Higashimoto Y, Appella E, Minucci S, Pandolfi PP, Pelicci PG (2000) PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406: 207-210
39. Pearson M, Pelicci PG (2001) PML interaction with p53 and its role in apoptosis and replicative senescence. Oncogene 20: 7250-7256
40. Pearson-White S (1993) SnoI, a novel alternatively spliced isoform of the ski protooncogene homolog, sno. Nucleic Acids Res 21: 4632-4638
41. Pelzer T, Lyons GE, Kim S, Moreadith RW (1996) Cloning and characterization of the murine homolog of the sno proto-oncogene reveals a novel splice variant. Dev Dyn 205: 114-125
42. Pfau R, Tzatsos A, Kampranis SC, Serebrennikova OB, Bear SE, Tsichlis PN (2008) Members of a family of JmjC domain-containing oncoproteins immortalize embryonic fibroblasts via a JmjC domain-dependent process. Proc Natl Acad Sci USA 10 5: 1907-1912
43. Ramel MC, Emery CS, Foulger R, Goberdhan DC, van den Heuvel M, Wilson C (2007) Drosophila SnoN modulates growth and patterning by antagonizing TGF-beta signalling. Mech Dev 124: 304-317
44. Rodier F, Campisi J, Bhaumik D (2007) Two faces of p53: aging and tumor suppression. Nucleic Acids Res 35: 7475-7484
45. Salomoni P, Pandolfi PP (2002) The role of PML in tumor suppression. Cell 108: 165-170
46. Schilling SH, Hjelmeland AB, Rich JN, Wang X-F (2008) TGF-b: a multipotential cytokine. In The TGF-beta Family (Cold spring Harbor monograph), Derynck R, Miyazono K (eds), pp 45-78. Cold Spring Harbor, New York: Cold Spring Harbor Press
47. Seeler JS, Dejean A (1999) The PML nuclear bodies: actors or extras? Curr Opin Genet Dev 9: 362-367
48. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593-602
49. Sharpless NE (2005) INK4a/ARF: a multifunctional tumor suppressor locus. Mutat Res 576: 22-38
50. Sharpless NE, Bardeesy N, Lee KH, Carrasco D, Castrillon DH, Aguirre AJ, Wu EA, Horner JW, DePinho RA (2001) Loss of p16Ink4a with retention of p19Arf predisposes mice to tumor-igenesis. Nature 413: 86-91
51. Sharpless NE, DePinho RA (2002) p53: good cop/bad cop. Cell 110:9-12
52. Shen TH, Lin HK, Scaglioni PP, Yung TM, Pandolfi PP (2006) The mechanisms of PML-nuclear body formation. Mol Cell 24: 331-339
53. Sherr CJ, DePinho RA (2000) Cellular senescence: mitotic clock or culture shock? Cell 102: 407-410
54. Shi Y, Massague J (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700
55. Shinagawa T, Dong H-D, Xu M, Maekawa T, Ishii S (2000) The sno gene, which encodes a component of the histone deacetylation complex, acts as a tumor suppressor in mice. EMBO J 19: 2280-2291
56. Stroschein SL, Bonni S, Wrana JL, Luo K (2001) Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN. Genes Dev 15: 2822-2836
57. Stroschein SL, Wang W, Zhou S, Zhou Q, Luo K (1999) Negative feedback regulation of TGF-beta signaling by the SnoN oncopro-tein. Science 286: 771-774
58. Sun Y, Liu X, Ng-Eaton E, Lodish HF, Weinberg RA (1999) SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling. Proc Natl Acad Sci USA 96: 12442-12447
59. Suzuki T, Minehata K, Akagi K, Jenkins NA, Copeland NG (2006) Tumor suppressor gene identification using retroviral inser-tional mutagenesis in Blm-deficient mice. EMBO J 25: 3422-3431
60. Takahashi Y, Lallemand-Breitenbach V, Zhu J, de The H (2004) PML nuclear bodies and apoptosis. Oncogene 23: 2819-2824
61. Todaro GJ, Green H (1963) Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J Cell Biol 17: 299-313
62. Villanacci V, Bellone G, Battaglia E, Rossi E, Carbone A, Prati A, Verna C, Niola P, Morelli A, Grassini M, Bassotti G (2008) Ski/ SnoN expression in the sequence metaplasia-dysplasia-adeno-carcinoma of Barrett's esophagus. Hum Pathol 39: 403-409
63. Wadhwa R, Sugihara T, Taira K, Kaul SC (2004) The ARF-p53 senescence pathway in mouse and human cells. Histol Histopathol 19: 311-316
64. Wan Y, Liu X, Kirschner MW (2001) The anaphase-promoting complex mediates TGF-beta signaling by targeting SnoN for destruction. Mol Cell 8: 1027-1039
65. Wilkinson DS, Tsai WW, Schumacher MA, Barton MC (2008) Chromatin-bound p53 anchors activated Smads and the mSin3A corepressor to confer transforming growth factor beta-mediated transcription repression. Mol Cell Biol 28: 1988-1998
66. Wu JW, Krawitz AR, Chai J, Li W, Zhang F, Luo K, Shi Y (2002) Structural mechanism of Smad4 recognition by the nuclear oncoprotein Ski: insights on Ski-mediated repression of TGF-beta signaling. Cell 111: 357-367
67. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, Cordon-Cardo C, Lowe SW (2007) Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445: 656-660
68. Zhang F, Lundin M, Ristimaki A, Heikkila P, Lundin J, Isola J, Joensuu H, Laiho M (2003) Ski-related novel protein N (SnoN), a negative controller of transforming growth factor-beta signaling, is a prognostic marker in estrogen receptor-positive breast carcinomas. Cancer Res 63: 5005-5010
69. Zhu Q, Krakowski AR, Dunham EE, Wang L, Bandyopadhyay A, Berdeaux R, Martin GS, Sun L, Luo K (2006) Dual role of SnoN in mammalian tumorigenesis. Mol Cell Biol 27: 314-319
70. Zhu Q, Pearson-White S, Luo K (2005) Requirement for the SnoN oncoprotein in transforming growth factor beta-induced oncogenic transformation of fibroblast cells. Mol Cell Biol 25: 10731-10744